Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells

OBJECTIVE: Malignant gliomas are the most common primary tumors of the central nervous system and the prognosis of patients with gliomas is poor. The combination of interferon-bata (IFN-β) and temozolomide (TMZ) has shown significant additive antitumor effects in human glioma xenograft models. Consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jae-Hyun, Ryu, Chung Heon, Kim, Mi Jin, Jeun, Sin-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Neurosurgical Society 2015
Materias:
Laboratory Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479712/
https://www.ncbi.nlm.nih.gov/pubmed/26113958
http://dx.doi.org/10.3340/jkns.2015.57.5.323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479712/
https://www.ncbi.nlm.nih.gov/pubmed/26113958
http://dx.doi.org/10.3340/jkns.2015.57.5.323

Ejemplares similares